GOVX
GeoVax Labs, Inc.
-0.01 (-2.62%)0.39USD141K成交股數2.9M市值–本益比(近四季)–股價營收比-100.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0-100% | 0-100% | 0-100% | 0-100% | 852K | 1.6M | 2.8M | 301K | 0 | 0 | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.1M | 3.9M | 3.0M | 5.0M | 4.7M | 5.4M | 7.4M | 4.3M | 4.4M | 6.2M | 6.9M | 4.7M |
| 銷售管理費用 | 1.3M | 1.4M | 1.4M | 1.3M | 1.5M | 1.7M | 1.2M | 1.1M | 1.5M | 1.5M | 1.7M | 1.5M |
| 營業利益 | −4.4M-18% | −5.3M-2% | −4.4M-24% | −6.4M+26% | −5.4M-8% | −5.4M-30% | −5.9M-32% | −5.1M-18% | −5.9M | −7.7M | −8.6M | −6.2M |
| 營業利益率 | – | – | – | – | -635.8% | -330.2% | -209.9% | -1,683.6% | – | – | – | – |
| 稅後淨利 | −4.4M-18% | −5.3M-2% | −4.4M-24% | −6.3M+25% | −5.4M-8% | −5.4M-29% | −5.8M-31% | −5.1M-15% | −5.9M | −7.6M | −8.4M | −5.9M |
| 淨利率 | – | – | – | – | -630.0% | -327.3% | -208.5% | -1,684.2% | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.1M | 1.3M | 3.1M | 5.0M | 3.1M | 7.4M | 8.6M | 1.6M | 769K | 6.5M | 12.7M | 17.8M |
| 應收帳款 | – | – | 0 | 0 | 533K | 1.5M | 548K | 301K | – | 0 | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 4.6M | 3.0M | 6.3M | 6.7M | 5.4M | 10.8M | 11.1M | 4.1M | 3.4M | 9.3M | 16.2M | 21.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.9M | 2.5M | 2.5M | – | – | – | – | – | – | – | – | – |
| 股東權益 | 1.8M | 494K | 3.8M | 4.9M | 2.8M | 7.9M | 8.5M | −2.3M | 54K | 5.8M | 9.1M | 17.2M |
| 負債比 | 62.1% | 83.4% | 39.7% | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.5M-41% | – | – | – | −6.0M | – | – | −5.7M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 17K | – | – | 0 | – | – | – |
| 自由現金流 | – | −3.5M-41% | – | – | – | −6.0M | – | – | −5.7M | – | – | – |
| 折舊攤銷 | – | 12K | – | – | – | 17K | – | – | 20K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -365.5% | – | – | – | – | – | – |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 82K
| NIH Grants | 82K | 100.0% | -78.9% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.5M | -37.1% | −21.5M | -862.3% | – | −21.5M |
| FY2024 | 4.0M | – | −25.0M | -632.0% | – | −24.7M |
| FY2023 | 0 | -100.0% | −26.0M | –% | – | −25.2M |
| FY2022 | 82K | -78.9% | −14.0M | -17,198.3% | – | −19.2M |
| FY2021 | 386K | -78.9% | −18.6M | -4,817.2% | -3.04 | −11.2M |
| FY2020 | 1.8M | +55.1% | −3.0M | -162.2% | -2.14 | −2.9M |
| FY2019 | 1.2M | +22.1% | −2.4M | -201.6% | -781.87 | −1.4M |
| FY2018 | 963K | – | −2.6M | -265.8% | -15610.33 | – |